Nuveen, LLC Ventyx Biosciences, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 168,420 shares of VTYX stock, worth $412,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168,420Holding current value
$412,629% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
126Shares Held
45.4MCall Options Held
35.2KPut Options Held
40.6K-
Black Rock Inc. New York, NY4.77MShares$11.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.23MShares$10.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$8.61 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$7.6 Million0.23% of portfolio
-
Sio Capital Management, LLC New York, NY2.58MShares$6.33 Million1.12% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $138M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...